CD4+CD25+CD127 regulatory cells play multiple roles in maintaining HIV-1 p24 production in patients on long-term treatment: HIV-1 p24-producing cells and suppression of anti-HIV immunity

Int J Infect Dis. 2015 Aug:37:42-9. doi: 10.1016/j.ijid.2015.06.008. Epub 2015 Jun 19.

Abstract

Background: A major question when attempting to eradicate and treat HIV-1 infection is how to reactivate latent proviruses. Stimulating HIV-1-specific cytolytic T lymphocytes (CTL) has been shown to facilitate the elimination of the latent viral reservoir after viral reactivation. Regulatory T (Treg) cells are known to be capable of lowering both HIV-specific immunoreactions and general immune activation during HIV-1 infection. It was hypothesized that the depletion of Treg cells could increase the HIV-1-specific cytolytic T lymphocyte response and reactivate HIV-1 p24 production.

Methods: Treg cells were isolated by isolation kit according to the surface marker of Treg cells. Real-time PCR method was used to quantify HIV-1 DNA. P24 antigens in the cell culture supernatant was done by ELISA. Cells activation and HIV specific HIV-1 CD8+ T cells were analyses using a FACSCalibur flow cytometer and CELLQUEST software.

Results: This study included both HIV-infected patients who were antiviral treatment-naïve and patients with sustained viral responses to antiretroviral therapy (ART) for 1 or 5 years. It was found that the HIV-DNA levels in Treg cells were approximately 10-fold higher than those in non-Treg CD4+ cells and that the depletion of Treg cells could enhance the frequency of HIV-1-specific CTL and immune activation after 5 years of effective ART.

Conclusions: CD4+CD25+CD127 regulatory cells play multiple roles in maintaining HIV-1 p24 production in long-term ART patients. Treg cells may be a target for eliminating the latent HIV reservoir after effective long-term ART.

Keywords: ART; Latent HIV; Treg.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Antigens, Viral / immunology
  • CD4 Antigens / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Female
  • HIV Core Protein p24 / immunology*
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • HIV-1 / immunology*
  • Humans
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Interleukin-7 Receptor alpha Subunit / immunology
  • Male
  • Middle Aged
  • T-Lymphocytes, Regulatory / immunology
  • Young Adult

Substances

  • Anti-Retroviral Agents
  • Antigens, Viral
  • CD4 Antigens
  • HIV Core Protein p24
  • Interleukin-2 Receptor alpha Subunit
  • Interleukin-7 Receptor alpha Subunit